BindingDB logo
myBDB logout

18 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
24831826 59 Small molecule inhibitors targeting activator protein 1 (AP-1).EBI University of Texas Medical Branch
24491635 4 Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.EBI National Defense Medical Center, Taiwan
19199792 3 Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.EBI National Cancer Institute-Frederick
18077363 314 A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.EBI University of Oxford
21806011 2 Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula.EBI National Cancer Institute-Frederick
21733691 2 Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.EBI NCI-Frederick
21458276 82 Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.EBI Sanford-Burnham Medical Research Institute
21306129 2 Inhibitors of the oncogenic transcription factor AP-1 from Podocarpus latifolius.EBI National Cancer Institute-Frederick
21316221 62 Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.EBI The Scripps Research Institute
20557982 7 Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.EBI B.V. Patel Pharmaceutical Education and Research Development Centre
17982447 1 Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH.EBI Yale University
20335039 1 Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.EBI B.V. Patel Pharmaceutical Education and Research Development Centre
19064304 4 Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents.EBI B.V. Patel Pharmaceutical Education and Research Development Centre
17531481 10 Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.EBI Yale University
17459703 111 Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.EBI UCB Pharma SA
17055723 17 Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.EBI Abbott Laboratories
11052805 24 Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide].EBI Signal Pharmaceuticals, Inc.